Talphera Inc (FRA:R5XA)
€ 0.46 -0.138 (-23.08%) Market Cap: 8.66 Mil Enterprise Value: -1.23 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 39/100

AcelRx Pharmaceuticals Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 13, 2019 / 04:10PM GMT
Release Date Price: €31.17 (-3.32%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

Hi there. My name is Evan Seigerman. I'm the Senior Large Cap Biotechnology Analyst here at Crédit Suisse. And welcome to the second day of our Global Healthcare Conference. And with us today, we have AcelRx Pharmaceuticals. And from AcelRx, we have Vince Agnotti. Thank you.

Vincent J. Angotti
AcelRx Pharmaceuticals, Inc. - CEO & Director

Angotti.

Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

Angotti.

Vincent J. Angotti
AcelRx Pharmaceuticals, Inc. - CEO & Director

Is that right?

Evan David Seigerman;dit Suisse AG;Vincent J. Angotti
CrÃ;Research Division - VP & Senior Equity Research Analyst;AcelRx Pharmaceuticals, Inc. - CEO &

© -

Angotti.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot